{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:41:00Z","timestamp":1790887260531,"version":"4.1.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T00:00:00Z","timestamp":1320019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Many therapies are being studied for the treatment of hot flashes for individuals with cancer, yet few studies have demonstrated safe and effective clinical benefit for those who suffer from this distressing symptom. The purpose of this paper is to assess the current options for the management of hot flashes, examining key endpoints from recent clinical trials and reviewing future directions. Hot flashes are a common stressful symptom for individuals with cancer, particularly women with a history of breast cancer and men with prostate cancer. Lifestyle modifications are proposed as the first step in the management of less severe hot flashes. Several publications have addressed nonhormonal agents as a treatment option for hot flashes. Newer antidepressant and anticonvulsant agents have been studied and show potential in treating vasomotor symptoms. Although many complementary and alternative therapies, including herbal medications and phytoestrogens, have been studied for the treatment of hot flashes, none are clinically recommended at this time. Additionally, further evidence is needed for supportive exercise such as yoga and relaxation techniques. Acupuncture may warrant further investigation in the reduction and severity of hot flashes in both men and women. Hormonal therapies, including estrogens and progestogens, are the most well-known and efficient agents in alleviating hot flashes; however, the safety of these agents is disputable.<\/jats:p>","DOI":"10.1634\/theoncologist.2011-0174","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T02:30:27Z","timestamp":1320114627000},"page":"1658-1664","source":"Crossref","is-referenced-by-count":74,"title":["Hot Flashes: A Review of Pathophysiology and Treatment Modalities"],"prefix":"10.1093","volume":"16","author":[{"given":"Phuong Khanh H.","family":"Morrow","sequence":"first","affiliation":[{"name":"Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Mattair","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,31]]},"reference":[{"key":"2021122304023358500_B1","first-page":"123","article-title":"Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions","volume":"2","author":"Pachman","year":"2010","journal-title":"Int J Womens Health"},{"key":"2021122304023358500_B2","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMcp054015","article-title":"Clinical practice. Management of menopausal symptoms","volume":"355","author":"Grady","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122304023358500_B3","first-page":"315","article-title":"Pathophysiology and management of hot flashes","volume":"4","author":"Dalal","year":"2006","journal-title":"J Support Oncol"},{"key":"2021122304023358500_B4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.1990.tb30316.x","article-title":"Hot flashes: Epidemiology and physiology","volume":"592","author":"Kronenberg","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"2021122304023358500_B5","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","article-title":"Side effects of adjuvant treatment of breast cancer","volume":"344","author":"Shapiro","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122304023358500_B6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"2021122304023358500_B7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/CBC.2000.n.004","article-title":"Tamoxifen-induced hot flashes","volume":"1","author":"Loprinzi","year":"2000","journal-title":"Clin Breast Cancer"},{"key":"2021122304023358500_B8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.1991.00400090120021","article-title":"Symptoms associated with tamoxifen treatment in postmenopausal women","volume":"151","author":"Love","year":"1991","journal-title":"Arch Intern Med"},{"key":"2021122304023358500_B9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.9-2-126","article-title":"Aromatase inhibitors for breast cancer in postmenopausal women","volume":"9","author":"Campos","year":"2004","journal-title":"The Oncologist"},{"key":"2021122304023358500_B10","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1200\/JCO.2007.14.4659","article-title":"Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group","volume":"26","author":"Paridaens","year":"2008","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMoa0810818","article-title":"BIG 1\u201398 Collaborative Group. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer","volume":"361","author":"Mouridsen","year":"2009","journal-title":"N Engl J Med"},{"key":"2021122304023358500_B12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","article-title":"ATAC Trialists' Group. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial","volume":"9","author":"Cuzick","year":"2008","journal-title":"Lancet Oncol"},{"key":"2021122304023358500_B13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-007-9700-y","article-title":"Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1\u201398","volume":"105","author":"Koeberle","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2021122304023358500_B14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/annonc\/mdp394","article-title":"Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: A prospective controlled study","volume":"21","author":"Mar Fan","year":"2010","journal-title":"Ann Oncol"},{"key":"2021122304023358500_B15","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.1998.16.8.2651","article-title":"Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group","volume":"16","author":"Levine","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.annonc.a057718","article-title":"The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group","volume":"1","author":"Goldhirsch","year":"1990","journal-title":"Ann Oncol"},{"key":"2021122304023358500_B18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/annonc\/mdn644","article-title":"A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)","volume":"20","author":"Loprinzi","year":"2009","journal-title":"Ann Oncol"},{"key":"2021122304023358500_B19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007611-199809000-00010","article-title":"Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer","volume":"91","author":"Schow","year":"1998","journal-title":"South Med J"},{"key":"2021122304023358500_B20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0090-4295(89)90385-3","article-title":"Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma","volume":"33","author":"Charig","year":"1989","journal-title":"Urology"},{"key":"2021122304023358500_B21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/77.11.1207","article-title":"Pathophysiology and treatment of hot flashes","volume":"77","author":"Shanafelt","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"suppl 12B","key":"2021122304023358500_B22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2005.09.046","article-title":"Hot flashes: behavioral treatments, mechanisms, and relation to sleep","volume":"118","author":"Freedman","year":"2005","journal-title":"Am J Med"},{"key":"2021122304023358500_B23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajhb.1077","article-title":"Physiology of hot flashes","volume":"13","author":"Freedman","year":"2001","journal-title":"Am J Hum Biol"},{"key":"2021122304023358500_B24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2008.02.006","article-title":"The menopausal hot flush\u2014anything new?","volume":"60","author":"Sturdee","year":"2008","journal-title":"Maturitas"},{"key":"2021122304023358500_B25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122304023358500_B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/BD-2006-24103","article-title":"Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women","volume":"24","author":"Velie","year":"2005","journal-title":"Breast Dis"},{"key":"2021122304023358500_B27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17\u03b2-estradiol dose for relief of hot flushes in postmenopausal women: A randomized controlled trial","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2021122304023358500_B28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2021122304023358500_B29","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"2021122304023358500_B30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"2021122304023358500_B31","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.2011.405","article-title":"Short-term use of unopposed estrogen: A balance of inferred risks and benefits","volume":"305","author":"Jungheim","year":"2011","journal-title":"JAMA"},{"key":"2021122304023358500_B32","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","article-title":"A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer","volume":"265","author":"Steinberg","year":"1991","journal-title":"JAMA"},{"key":"2021122304023358500_B33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"key":"2021122304023358500_B34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: A randomized study","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol"},{"key":"2021122304023358500_B35","first-page":"225","article-title":"Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss","volume":"94","author":"Leonetti","year":"1999","journal-title":"Obstet Gynecol"},{"key":"2021122304023358500_B36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1258\/mi.2009.009014","article-title":"A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women","volume":"15","author":"Benster","year":"2009","journal-title":"Menopause Int"},{"key":"2021122304023358500_B37","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122304023358500_B38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02109923","article-title":"Studies with clonidine (Dixarit) in menopausal women","volume":"227","author":"Schindler","year":"1979","journal-title":"Arch Gynecol"},{"key":"2021122304023358500_B39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.1.5905.409","article-title":"Menopausal flushing: Double-blind trial of a non-hormonal medication","volume":"1","author":"Clayden","year":"1974","journal-title":"Br Med J"},{"key":"2021122304023358500_B40","first-page":"583","article-title":"Effect of clonidine on hot flashes in postmenopausal women","volume":"60","author":"Laufer","year":"1982","journal-title":"Obst Gynecol"},{"key":"2021122304023358500_B41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B42","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"2021122304023358500_B43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/gme.0b013e3181679150","article-title":"Mayo Clinic and North Central Cancer Treatment Group hot flash studies: A 20-year experience","volume":"15","author":"Loprinzi","year":"2008","journal-title":"Menopause"},{"key":"2021122304023358500_B44","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B45","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"2021122304023358500_B46","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2009.26.6379","article-title":"Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG Trial N05C9","volume":"28","author":"Barton","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B47","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"2021122304023358500_B48","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B49","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2021122304023358500_B50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"2021122304023358500_B51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2021122304023358500_B52","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","article-title":"Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5","volume":"25","author":"Loprinzi","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B56","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","article-title":"Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group trial","volume":"18","author":"Quella","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2009.23.5150","article-title":"Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: A randomized controlled trial","volume":"28","author":"Walker","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122304023358500_B58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1464-410X.2008.07884.x","article-title":"Auricular acupuncture: A novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer","volume":"103","author":"Harding","year":"2009","journal-title":"BJU Int"},{"key":"2021122304023358500_B59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/gme.0b013e3181a48abd","article-title":"Acupuncture for vasomotor menopausal symptoms: A systematic review","volume":"16","author":"Cho","year":"2009","journal-title":"Menopause"},{"key":"2021122304023358500_B60","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2010.0086","article-title":"Nonhormonal management of hot flashes for women on risk reduction therapy","volume":"8","author":"Sideras","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"2021122304023358500_B61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GME.0000108177.85442.71","article-title":"Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society","volume":"11","author":"North American Menopause Society","year":"2004","journal-title":"Menopause"},{"key":"2021122304023358500_B62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.maturitas.2007.01.012","article-title":"A pilot study of a Hatha yoga treatment for menopausal symptoms","volume":"57","author":"Booth-LaForce","year":"2007","journal-title":"Maturitas"},{"key":"2021122304023358500_B63","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/gme.0b013e318167b902","article-title":"Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: A randomized control study","volume":"15","author":"Chattha","year":"2008","journal-title":"Menopause"},{"key":"2021122304023358500_B64","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/gme.0b013e31818ffe39","article-title":"Yoga for menopausal symptoms: A systematic review","volume":"16","author":"Lee","year":"2009","journal-title":"Menopause"},{"key":"2021122304023358500_B65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(03)00187-7","article-title":"Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy","volume":"48","author":"Lindh-Astrand","year":"2004","journal-title":"Maturitas"},{"key":"2021122304023358500_B66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2114\/jpa.23.143","article-title":"A 12-week structured education and exercise program improved climacteric symptoms in middle-aged women","volume":"23","author":"Ueda","year":"2004","journal-title":"J Physiol Anthropol Appl Human Sci"},{"key":"2021122304023358500_B67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.GME.0000113932.56832.27","article-title":"Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women","volume":"11","author":"Aiello","year":"2004","journal-title":"Menopause"},{"key":"2021122304023358500_B68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9378(11)91425-2","article-title":"Behavioral treatment of menopausal hot flushes\u2013evaluation by ambulatory monitoring","volume":"167","author":"Freedman","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2021122304023358500_B69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.maturitas.2004.05.017","article-title":"Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women","volume":"51","author":"Nedstrand","year":"2005","journal-title":"Maturitas"},{"key":"2021122304023358500_B70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/gme.0b013e31805c08dc","article-title":"Psychoeducational interventions to alleviate hot flashes: A systematic review","volume":"15","author":"Tremblay","year":"2008","journal-title":"Menopause"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2011-0174","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2011-0174","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/11\/1658\/41855553\/oncolo_16_11_1658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/11\/1658\/41855553\/oncolo_16_11_1658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T10:35:46Z","timestamp":1640255746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/16\/11\/1658\/6400765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,31]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,10,31]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2011-0174","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,11,1]]},"published":{"date-parts":[[2011,10,31]]}}}